Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rivastigmine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rivastigmine 3mg capsules
0411000E0AAABAB
|
Rivastigmine | Rivastigmine | Central Nervous System | 24,210 |
|
Rivastigmine 9.5mg/24hours transdermal patches
0411000E0AAAGAG
|
Rivastigmine | Rivastigmine | Central Nervous System | 23,359 |
|
Rivastigmine 1.5mg capsules
0411000E0AAAAAA
|
Rivastigmine | Rivastigmine | Central Nervous System | 17,715 |
|
Alzest 9.5mg/24hours transdermal patches
0411000E0BGABAG
|
Alzest | Rivastigmine | Central Nervous System | 11,858 |
|
Rivastigmine 4.6mg/24hours transdermal patches
0411000E0AAAFAF
|
Rivastigmine | Rivastigmine | Central Nervous System | 10,505 |
|
Rivastigmine 4.5mg capsules
0411000E0AAACAC
|
Rivastigmine | Rivastigmine | Central Nervous System | 10,114 |
|
Alzest 4.6mg/24hours transdermal patches
0411000E0BGAAAF
|
Alzest | Rivastigmine | Central Nervous System | 10,073 |
|
Rivastigmine 6mg capsules
0411000E0AAADAD
|
Rivastigmine | Rivastigmine | Central Nervous System | 7,370 |
|
Rivastigmine 13.3mg/24hours transdermal patches
0411000E0AAAIAI
|
Rivastigmine | Rivastigmine | Central Nervous System | 5,429 |
|
Alzest 13.3mg/24hours transdermal patches
0411000E0BGACAI
|
Alzest | Rivastigmine | Central Nervous System | 1,040 |
|
Rivastigmine 2mg/ml oral solution sugar free
0411000E0AAAEAE
|
Rivastigmine | Rivastigmine | Central Nervous System | 916 |
|
Exelon 9.5mg/24hours transdermal patches
0411000E0BBAGAG
|
Exelon | Rivastigmine | Central Nervous System | 725 |
|
Exelon 4.6mg/24hours transdermal patches
0411000E0BBAFAF
|
Exelon | Rivastigmine | Central Nervous System | 451 |
|
Prometax 9.5mg/24hours transdermal patches
0411000E0BHAAAG
|
Prometax | Rivastigmine | Central Nervous System | 328 |
|
Almuriva 9.5mg/24hours transdermal patches
0411000E0BKABAG
|
Almuriva | Rivastigmine | Central Nervous System | 300 |
|
Almuriva 4.6mg/24hours transdermal patches
0411000E0BKAAAF
|
Almuriva | Rivastigmine | Central Nervous System | 159 |
|
Zeyzelf 4.6mg/24hours twice weekly transdermal patches
0411000E0BLAAAF
|
Zeyzelf | Rivastigmine | Central Nervous System | 130 |
|
Exelon 13.3mg/24hours transdermal patches
0411000E0BBAHAI
|
Exelon | Rivastigmine | Central Nervous System | 125 |
|
Zeyzelf 9.5mg/24hours twice weekly transdermal patches
0411000E0BLABAG
|
Zeyzelf | Rivastigmine | Central Nervous System | 103 |
|
Erastig 13.3mg/24hours transdermal patches
0411000E0BFACAI
|
Erastig | Rivastigmine | Central Nervous System | 100 |
|
Prometax 4.6mg/24hours transdermal patches
0411000E0BHABAF
|
Prometax | Rivastigmine | Central Nervous System | 89 |
|
Almuriva 13.3mg/24hours transdermal patches
0411000E0BKACAI
|
Almuriva | Rivastigmine | Central Nervous System | 13 |
|
Rivastigmine 2mg/ml oral solution
0411000E0AAAHAH
|
Rivastigmine | Rivastigmine | Central Nervous System | 1 |
|
Eluden 4.6mg/24hours transdermal patches
0411000E0BJAAAF
|
Eluden | Rivastigmine | Central Nervous System | No data available |
|
Eluden 9.5mg/24hours transdermal patches
0411000E0BJABAG
|
Eluden | Rivastigmine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.